On August 3, in response to the Trump administration’s threats to add $200 billion of tariffs on Chinese goods, the Chinese Ministry of Commerce announced that they will tax 5% to 25% on an additional $60 billion worth of U.S. goods. The... Read More
Last month, the China National Drug Administration (CNDA), formerly known as the China Food and Drug Administration (CFDA), released a fourth batch of Class II and III medical devices that may be exempted from the requirement to conduct local clinical studies to... Read More
Mercer, the large human resources consulting firm, predicts solid employment and wage growth throughout the Asian region in 2018 to 2019. One of the strongest areas for growth will be in the life sciences industry in China. Since there has been a... Read More
Many Chinese citizens today are demanding better drugs and treatments for diseases. IQVIA Holdings predicts that the China drug market will grow by 30% over the next few years, reaching $170 billion in sales. Last year, China added about 100 Western drugs... Read More
Under popular pressure to boost the affordability of cancer medications, China’s health insurance regulator announced in August that it will add a range of cancer drugs to the list of those already covered by the national medical insurance system. At the same... Read More
This article was originally published on Medtech Intelligence Hospitals in key Asian countries are enjoying strong growth prospects, spurred by aging populations, a rising middle class, an expansion of public health insurance, and the encouragement of private and foreign investment in the... Read More
The China Food and Drug Administration (CFDA) is the administrative body responsible for the regulation of medical devices and pharmaceuticals on the Chinese mainland. The CFDA is separated into various departments that are individually responsible for the registration, tracking, and monitoring of medical... Read More
Eager to hasten the availability of medicines for rare diseases and life-threatening illnesses to Chinese consumers, China is easing approval procedures for orphan drug imports. At a meeting this summer, the China State Council set a review timeline of just three months... Read More
Flush with cash and eager to gain earlier and easier access to innovative drug technologies, Chinese investors have been pumping money into Western biotech startups over the past two years. But despite this recent trend, U.S. President Donald Trump’s plan to limit... Read More
More than 450 million Chinese—one in three people in the world’s most populous country—suffer from nearsightedness, according to statistics released by China’s National Health Commission in June. Sixty years ago, 10%-20% of the Chinese population was short-sighted. Today, one third—including a startling... Read More